Stocktoria
GUIDED THERAPEUTICS INC GTHP
OTC · OOTC · stock
GUIDED THERAPEUTICS INC financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $767,000 | $7,000 | $98,000 | $13,000 | $81,000 | $102,000 | $36,000 | $57,000 | $244,000 | $0 |
| Gross profit | $571,000 | $2,000 | $36,000 | -$68,000 | $20,000 | $143,000 | -$34,000 | -$32,000 | -$286,000 | $112,000 |
| R&D expense | $469,000 | $526,000 | $228,000 | $77,000 | $69,000 | $143,000 | $122,000 | $244,000 | $334,000 | $733,000 |
| Operating income | -$2.4M | -$2.1M | -$3.5M | -$3.3M | -$2.4M | -$1.1M | -$937,000 | -$1.5M | -$3.1M | -$3.8M |
| Interest expense | $617,000 | $381,000 | $278,000 | $582,000 | $1.1M | $1.1M | $1.4M | $1.8M | $1.1M | $1.9M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$3.2M | -$2.4M | -$3.5M | -$4.3M | -$2.1M | -$279,000 | -$1.9M | $1.0M | -$10.7M | -$4.0M |
| EPS (diluted) | $-0.04 | $-0.05 | $-0.07 | $-0.15 | $-0.18 | $-0.04 | $-0.58 | $0.01 | $0.00 | — |
| Operating cash flow | -$1.1M | -$1.1M | -$1.7M | -$1.5M | -$1.6M | -$1.9M | -$806,000 | -$1.4M | -$1.1M | -$1.8M |
| Free cash flow | -$1.1M | -$1.1M | -$1.7M | -$1.5M | -$1.6M | -$1.9M | -$806,000 | — | — | — |
| Cash & equivalents | — | — | — | $2.3M | $643,000 | $182,000 | $899,000 | $0 | $1,000 | $14,000 |
| Inventory | $448,000 | $633,000 | $632,000 | $548,000 | $571,000 | $605,000 | $48,000 | $114,000 | $182,000 | $773,000 |
| Total assets | $1.3M | $1.4M | $1.7M | $3.4M | $2.0M | $1.4M | $1.2M | $236,000 | $406,000 | $1.5M |
| Total liabilities | $7.3M | $6.3M | $5.5M | $6.2M | $7.5M | $12.2M | $18.1M | $16.1M | $19.8M | $10.8M |
| Shareholders' equity | -$6.0M | -$4.9M | -$3.8M | -$2.9M | -$5.4M | -$10.9M | -$16.9M | -$15.8M | -$19.4M | -$9.3M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +10857.1% | -92.9% | +653.8% | -84.0% | -20.6% | +183.3% | -36.8% | -76.6% | — | -100.0% |
| Net income growth | — | — | — | — | — | — | -289.1% | — | — | — |
| EPS growth | — | — | — | — | — | — | -4302.9% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000924515 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.